ACE inhibitor or ARB to prevent kidney disease

Congratulations to PL editorial advisory board member, Dr. Craig Williams, PharmD, FNLA, BCPS, for his recent Pharmacotherapy editorial. It dispels the common belief that all diabetes patients with microalbuminuria need an ACE inhibitor or ARB, and complements our November 2012 article on the subject. Click here to view Dr. Williams' editorial.

Patients with diabetes do NOT necessarily benefit from an ACE inhibitor or ARB to prevent kidney disease.

Most of us were taught that diabetes patients who spill small amounts of albumin in their urine should get an ACEI or ARB.

Current diabetes guidelines still recommend starting an ACEI or ARB for this MICROalbuminuria...even in patients without hypertension.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote